8-K: SelectQuote Reports Strong Q3 FY2026 Results

SelectQuote, Inc. announced its third quarter fiscal year 2026 financial results, showcasing revenue growth and improved profitability.

Summary

• SelectQuote, Inc. reported third quarter fiscal year 2026 consolidated revenue of $430.9 million, an increase from $408.2 million in the prior year's third quarter.
• Net income for the quarter was $40.2 million, up from $26.0 million in the same period last year.
• Adjusted EBITDA reached $44.6 million, an increase from $37.7 million in the prior year's third quarter.
• The Senior segment reported revenue of $182.9 million and Adjusted EBITDA of $58.6 million, with 175,557 Medicare Advantage policies approved.
• The Healthcare Services segment generated $199.4 million in revenue and $5.3 million in Adjusted EBITDA, serving 116,616 SelectRx members.
• The Life segment reported revenue of $47.9 million and Adjusted EBITDA of $6.1 million.
• The company reaffirmed its fiscal year 2026 guidance, expecting revenue between $1.61 billion and $1.71 billion, and Adjusted EBITDA between $90 million and $100 million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong year-over-year growth in revenue and net income, alongside a significant increase in Adjusted EBITDA. The reaffirmation of guidance and positive management commentary contribute to a favorable sentiment.

Positives

• Consolidated revenue increased by 6% year-over-year to $430.9 million.
• Consolidated net income significantly improved to $40.2 million from $26.0 million in the prior year.
• Adjusted EBITDA saw a substantial increase of 18% year-over-year to $44.6 million.
• The Senior segment experienced an 8% revenue increase and a 28% rise in Adjusted EBITDA, with a positive $14 million change in estimate for commissions receivable.
• Senior segment Adjusted EBITDA margins were strong at 32%.
• Healthcare Services revenue grew 5% to $199.4 million, with SelectRx members increasing by 11% year-over-year to 116,616.
• The revenue to customer acquisition cost (CAC) multiple reached a high of 6.7x, indicating strong marketing efficiency.
• The company reaffirmed its full-year financial outlook, suggesting confidence in continued performance.

Negatives

• The nine-month year-to-date revenue for the Senior segment decreased by 3% compared to the prior year.
• Nine-month year-to-date Adjusted EBITDA for the Senior segment decreased by 9%.
• Healthcare Services Adjusted EBITDA decreased by 18% year-over-year for the third quarter.
• Life segment Adjusted EBITDA decreased by 4% year-over-year for the third quarter.
• Total operating expenses per MA/MS policy increased by 22% for the twelve months ended March 31, 2026, driven by the Healthcare Services segment.

Risks

• Reliance on a limited number of insurance carrier partners and potential termination of relationships.
• Existing and future laws and regulations affecting the health insurance market.
• Changes in health insurance products and market dynamics.
• Competition from carriers selling directly to consumers and online brokers.
• Downturns in the senior health, life, automotive, and home insurance industries.
• Failure to enroll individuals during the Medicare annual enrollment period.
• Disruptions or failures of technological infrastructure and platform.
• Cybersecurity breaches or other attacks involving company systems or partners.

Future Outlook

SelectQuote reaffirmed its financial outlook for fiscal year 2026, projecting revenue in the range of $1.61 billion to $1.71 billion and Adjusted EBITDA between $90 million and $100 million, driven by operating execution and technology leverage.

Management Comments

• "SelectQuote delivered consistent profit and cash flow for another quarter, despite market shifts for both Medicare Advantage and prescription drugs."
• "We reaffirm our financial outlook for fiscal 2026 driven by operating execution by our agents and continued leverage of our information and technology advantages."
• "Revenue to customer acquisition cost of 6.7X represented a high water mark for the company, and more importantly, signals the value our differentiated healthcare service model provides to policyholders and prescription drug customers."
• "Our goal to drive reliable and consistent profit, and cash flow growth remains priority number one."
• "We believe the improvement to our capital structure to date, combined with the continued maturation of our SelectRx business, positions SelectQuote to materially expand cash flow in the years ahead."

Industry Context

StockSavvy.ai notes that SelectQuote's performance in Q3 FY2026 reflects resilience amidst market shifts in Medicare Advantage and prescription drugs, with a notable emphasis on leveraging technology and agent execution to drive profitability and cash flow. The company's strategy appears focused on expanding its healthcare services segment while maintaining strong performance in its core senior market.

Comparison to Industry Standards

• The reported Adjusted EBITDA margin of 32% for the Senior segment is robust and likely exceeds industry averages for insurance brokerage services, especially considering the positive impact of a $14 million change in estimate.
• The revenue to customer acquisition cost (CAC) multiple of 6.7x for the Senior and Healthcare Services divisions indicates efficient lead generation and conversion, a key performance indicator in the competitive insurance and healthcare markets.
• The 11% year-over-year growth in SelectRx members for the Healthcare Services segment demonstrates successful expansion in the pharmacy benefit management (PBM) space, a growing area within healthcare services.
• While overall revenue grew, the slight year-over-year decline in nine-month Senior segment revenue and the decrease in Healthcare Services Adjusted EBITDA warrant monitoring against industry trends in healthcare cost containment and PBM reimbursement rates.

Stakeholder Impact

• Shareholders: Improved profitability and reaffirmed guidance are positive indicators for shareholder value.
• Employees: Continued operational execution and technology leverage may support job stability and growth opportunities.
• Customers: The company's focus on providing value through its differentiated healthcare service model and agent expertise is intended to benefit policyholders and prescription drug customers.
• Insurance Carriers: Strong performance in policy approvals and customer acquisition can strengthen relationships with carrier partners.

Next Steps

• Continue to execute on operating plans to drive profit and cash flow growth.
• Further leverage information and technology advantages.
• Continue maturation of the SelectRx business to expand cash flow.
• Monitor market shifts in Medicare Advantage and prescription drugs.

Key Dates

Recommendation

The company demonstrated solid year-over-year growth in key financial metrics and reaffirmed its guidance, indicating expected performance. However, the slight year-over-year declines in nine-month year-to-date metrics for the Senior segment and the decrease in Healthcare Services Adjusted EBITDA, coupled with ongoing industry risks, suggest a 'hold' recommendation until further sustained positive trends are evident.

Keywords

SelectQuote, SEC Filing, 8-K, Financial Results, Quarterly Report, Medicare Advantage, Healthcare Services, Adjusted EBITDA